Elizabeth Plimack, MD, MS
Fox Chase Cancer Center
333 Cottman Ave
Philadelphia, PA 19111
American Board of Internal Medicine
With a diagnosis of cancer comes uncertainty and fear for many patients. As a medical oncologist, my first job is to help each patient understand his or her diagnosis. With that understanding, together we can design the best plan of action. At Fox Chase, each patient has the benefit of an interdisciplinary team working together to ensure the highest quality care. This interdisciplinary approach is crucial in determining and implementing the best treatment plan. I specialize in the treatment of kidney, bladder, prostate and testicular cancer, and my clinical practice is focused on these diseases. By concentrating exclusively on genitourinary malignancies I am able to offer expert knowledge as well as access to both standard treatments and emerging therapies in the form of clinical trials. The pace of scientific discovery has accelerated in recent decades, and fortunately we have seen these discoveries translate into meaningful improvements in cancer treatments. As part of the genitourinary group here at Fox Chase, I am proud to be a part of a team of distinguished researchers who have pioneered many of these new treatments. My particular research efforts focus on the development of new therapies for bladder and kidney cancer.
MS in Patient Based Biologic Research, University of Texas Graduate School of Biomedical Sciences, 2008.
MD with Honors in Pathology, New York University School of Medicine, 2002.
Internship and Residency in Internal Medicine, New York University Medical Center / Bellevue Hospital
Fellow, Medical Oncology, University of Texas MD Anderson Cancer Center, Chief Fellow
Translational Research; Kidney Cancer; Bladder Cancer